Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries

Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries

Item
http://www.wikidata.org/entity/Q28075884
Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.Parallel Evolution of Group B Streptococcus Hypervirulent Clonal Complex 17 Unveils New Pathoadaptive Mutations.Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model.Immunization with a Latch Peptide Provides Serotype-Independent Protection against Group B Streptococcus Infection in Mice.Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease.Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy.Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.Clinical and laboratory features of Group B Streptococcus meningitis in infants and newborns: study of 848 cases in France from 2001-2014.Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches.Maternal group B Streptococcus recto vaginal colonization increases the odds of stillbirth: evidence from Eastern EthiopiaStable Expression of Modified Green Fluorescent Protein in Group B Streptococci To Enable Visualization in Experimental Systems
P2860

Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries

Item
http://www.wikidata.org/entity/Q28075884
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Group B Streptococcus vaccine ...... ow and middle income countries
@ast
Group B Streptococcus vaccine ...... ow and middle income countries
@en
Group B Streptococcus vaccine ...... ow and middle income countries
@nl
type
label
Group B Streptococcus vaccine ...... ow and middle income countries
@ast
Group B Streptococcus vaccine ...... ow and middle income countries
@en
Group B Streptococcus vaccine ...... ow and middle income countries
@nl
prefLabel
Group B Streptococcus vaccine ...... ow and middle income countries
@ast
Group B Streptococcus vaccine ...... ow and middle income countries
@en
Group B Streptococcus vaccine ...... ow and middle income countries
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P478
P50
P577
P698
P932
P3181
P356
P1433
P1476
Group B Streptococcus vaccine ...... ow and middle income countries
@en
P2093
P2860
P304
P31
P3181
P356
10.12688/F1000RESEARCH.9363.1
P407
P478
P50
P577
P698
P932